NIKKEI 225
38,152.36 -27.10 (-0.07%) HANG SENG
19,091.32 -23.74 (-0.12%) CRUDE OIL
79.23 +0.11 (+0.14%) GOLD FUTURES
2,349.40 +6.40 (+0.27%) DOW
39,431.51 -81.29 (-0.21%) Bitcoin GBP
49,755.37 +1,085.69 (+2.23%)
Hercules Capital, Inc. (0J4M.L)
- Business Wire
Hercules Capital Announces Date of 2024 Annual Meeting of Stockholders
SAN MATEO, Calif., May 13, 2024--Hercules Capital, Inc. (NYSE: HTGC) ("Hercules" or the "Company"), will conduct its 2024 Annual Meeting of Stockholders by virtual meeting on Thursday, June 20, 2024 at 9:00 a.m. (Pacific Time). The proxy statement for the meeting was filed on April 23, 2024 and mailed to stockholders of record as of April 19, 2024.
- Zacks
bluebird (BLUE) Tops on Q1 Sales, Zynteglo Progresses Well
bluebird (BLUE) beats sales estimates in the first quarter on increased Zynteglo product revenues. The company is on track with the ongoing launch of its gene therapies.
- Globe Newswire
Verona Pharma Announces $650 Million Strategic Financing with Oaktree and OMERS
Non-dilutive funding will support planned US commercial launch and expansion of ensifentrine’s clinical activities Cash runway extended beyond 2026 LONDON and RALEIGH, N.C., May 09, 2024 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma”), announces it and its wholly-owned subsidiary, Verona Pharma, Inc. (“VPI” and together with Verona Pharma, the “Company”), have entered into strategic financing agreements providing access to up to $650 million from funds managed by Oaktree C
